[Federal Register Volume 85, Number 13 (Tuesday, January 21, 2020)]
[Notices]
[Pages 3395-3396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00882]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a two-day 
meeting in-person meeting. The meeting will be open to the public and 
public comment sessions will be held during the meeting.

DATES: The meeting will be held on Tuesday and Wednesday, February 13-
14, 2020. The confirmed meeting times and agenda will be posted on the 
NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as 
soon as they become available.

ADDRESSES: Instructions regarding attending this meeting will be posted 
online at: http://www.hhs.gov/nvpo/nvac/meetings/index.html at least 
one week prior to the meeting. Pre-registration is required for those 
who wish to attend the meeting or participate in one of the public 
comment sessions. Please register at http://www.hhs.gov/nvpo/nvac/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, at the Office of Infectious

[[Page 3396]]

Disease and HIV/AIDS Policy, U.S. Department of Health and Human 
Services, Mary E. Switzer Building, Room L618, 330 C Street SW, 
Washington, DC 20024. Phone: (202) 795-7611; email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was 
mandated to establish the National Vaccine Program to achieve optimal 
prevention of human infectious diseases through immunization and to 
achieve optimal prevention against adverse reactions to vaccines. The 
NVAC was established to provide advice and make recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program's responsibilities. The Assistant Secretary for Health serves 
as Director of the National Vaccine Program.
    During the February 2020 NVAC meeting, sessions will focus on 
vaccine innovation and vaccine confidence with updates from 
subcommittees and members. Please note that agenda items are related to 
charges of the committee and are subject to change, as priorities 
dictate. Information on the final meeting agenda will be posted prior 
to the meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office ([email protected]) at least five 
business days prior to the meeting.

    Dated: January 3, 2020.
Ann Aikin,
Acting Designated Federal Official, Office of Infectious Disease and 
HIV/AIDS Policy.
[FR Doc. 2020-00882 Filed 1-17-20; 8:45 am]
 BILLING CODE 4150-44-P